Health Condition 1: C50- Malignant neoplasm of breast Health Condition 2: C569- Malignant neoplasm of unspecifiedovary Health Condition 3: C34- Malignant neoplasm of bronchus andlung Health Condition 4: C61- Malignant neoplasm of prostate Health Condition 5: C189- Malignant neoplasm of colon, unspecified Health Condition 6: C760- Malignant neoplasm of head, face and neck Health Condition 7: C539- Malignant neoplasm of cervix uteri, unspecified Health Condition 8: F30-F39- Mood [affective] disord
Conditions
Interventions
Intervention1: Self-monitoring and integrated referral system.: An internet (web-based) and mobile-technology based system to self-monitor their symptoms of depression. An Electronic Decision Support
8 modules, each lasting 1 hour delivered over 8-10 weeks using a mix of in-person and online modes. The modules will include elements related to treatment pattern and objectives, realization of emotio
8
modules, each lasting 1 hour
delivered over 8-10 weeks using a mix of in-person and online modes. The modules will
include elements related to
treatment pattern and objectives, realization of
emotio
Behavioral activa
Sponsors
The George Institute for Global Health, India
Eligibility
Inclusion criteria
Inclusion criteria: 1. Consenting adult patients (18 years and above) suffering from breast, cervix, ovarian, lung, prostrate, colon, head, and neck cancer with comorbid depression as per screen positive cut-off score on PHQ9/GAD7 attending the relevant departments of the 3 hospitals. 2. Newly diagnosed (clinically or confirmed by radiological/pathological reports) patients (within 3 months, which includes patients with recurring/ secondary cancer) will be recruited from both inpatient and outpatients.
Exclusion criteria
Exclusion criteria: 1. Patients at imminent risk of suicide based on clinical assessment, or showing aggressive behavior, or lacking insight due to psychotic features; 2. Patients who score 2 or more on the Eastern Cooperative Oncology Group Performance Status (ECOG-PS); 3. Patients and caregivers who are unable to read Hindi/ English/ Punjabi/ Kannada/ Telegu (that would prevent them from responding to the self-monitoring questions). 4. Patients who are unable to speak and communicate because of the disease and treatment which hinders their participation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| A. Change in PHQ-9 depression scores in both the intervention arms compared to the control arm. B. Change in WHO-5 wellbeing scores in both the intervention arms compared to control arm.Timepoint: A. Baseline (just before randomization) and at 6 months since randomization. B. Baseline (just before randomization) and at 6 months since randomization. | — |
Secondary
| Measure | Time frame |
|---|---|
| A. Changes in PHQ-9 depression scores. B. Changes in Quality of life WHOQol-Bref scores.Timepoint: A. Baseline (just before randomization) & at 9 months after randomization. B. Baseline (just before randomization) & at 9 months after randomization. | — |
Countries
India
Contacts
Public ContactDr Mercian Daniel
George Institute for Global Health
Outcome results
None listed